But I think the broad takeaway for investors from today is that PepsiCo is committed to bringing better focus to this company. You know, I've covered this company a long time and its primary competitors, Coca-Cola, Keurig, Dr. . Pepper, it's a primo water monster.How they differ from PepsiCo is so much more focused on specific categories. But PepsiCo, with the urging of the activist, urging them on, is bringing more focus to this company. And what I mean is they're rationalizing a lot of the SKUs that reall ...

Core Insights - PepsiCo reported a 5.6% increase in revenue for Q4, reaching $29.3 billion, surpassing Wall Street's expectation of $28.9 billion [1] Revenue and Volume Performance - Snack volumes, including Doritos and Cheetos, decreased by 1%, while North American beverage volumes fell by 4%. Globally, beverage volumes increased by 1%, while food volumes declined by 2% [2] - The company implemented a global price increase of 4.5% during the quarter, with North American beverage prices rising by 7% and snack prices increasing by 1% [2] Strategic Changes and Investor Influence - PepsiCo plans to reduce prices and cut nearly 20% of its product offerings as part of an agreement with activist investor Elliott Investment Management, acknowledging that previous price hikes and changing consumer preferences have negatively impacted demand [3] - Elliott Investment Management, which acquired a $4 billion stake in PepsiCo, has urged the company to make changes due to slowing growth and declining profits in its North American food and beverage sector [4] New Product Introductions - The company is accelerating the launch of new products with simpler and more functional ingredients, such as Doritos Protein and Simply NKD Cheetos and Doritos, which are free from artificial flavors or colors [4] - PepsiCo's new product, Pepsi Prebiotic, sold out within 30 hours of its Black Friday launch and will soon be available nationwide [5] Earnings Performance - Adjusted for one-time items, PepsiCo reported earnings of $2.26 per share in Q4, exceeding analysts' expectations [5]

PepsiCo Planning Price Cuts—Joining Target Amid Affordability Crunchhttps://t.co/nwKOPidw9r https://t.co/5V9K6aOUEe ...

The pharmaceutical giant’s deal with Trump to cut prices has little impact on the bottom line–but removes a lot of regulatory uncertainty. Investors love it.https://t.co/4kLjFDNWlJhttps://t.co/4kLjFDNWlJ ...

Novartis is looking at ways to propose price cuts to the US by the end of the month, its CEO told Neue Zuercher Zeitung https://t.co/vlBrxOM3jm ...

China’s leader is rebuking carmakers and other sectors for giving customers too good a deal. Yet his own policies are to often blame for the price cuts https://t.co/dfNX0EdVLe ...